Mutational Signature Indicates Risk of Kidney Cancer Recurrence,DNA sequencing can identify mutations that predict...
kidney cancer
Roche, Exelixis' Tecentriq-Cabometyx pair fails again—this time in kidney cancer,For a new phase 3...
New Method of Treating Kidney Cancer Discovered by Scientists - 23.11.2022, Sputnik International,A new...